---
id: "entity-gold"
type: "entity"
entityType: "organization"
canonicalName: "Global Initiative for Chronic Obstructive Lung Disease (GOLD)"
aliases: ["GOLD"]
source_timestamps: ["§ The 4C Framework for Building Generative Readiness"]
tags: ["medical-guidelines", "authoritative-source"]
related: ["claim-guideline-format-change-impact", "entity-gsk", "concept-machine-readable-content"]
sources: ["geo"]
sourceVaultSlug: "hbr-seg-geo"
originDay: 3
articleStem: "hbr-tier1-01-gen-ai-b2b-buying"
sourceUrl: "https://hbr.org/2026/06/how-gen-ai-is-disrupting-b2b-buying-decisions"
sourceTitle: "How Gen AI is Disrupting B2B Buying Decisions"
---
# Global Initiative for Chronic Obstructive Lung Disease (GOLD)

**GOLD** (Global Initiative for Chronic Obstructive Lung Disease) is the leading global clinical-guideline body for **COPD**, publishing globally recognized management/prevention strategy documents and pocket guides, with periodic updates.

**Role in the source:** GOLD is the cautionary tale for [[concept-machine-readable-content]]. A change to its website formatting — from *embedded PDFs* to *click-to-download files* — broke machine readability, causing LLMs to keep citing the **outdated 2024** guidelines instead of current recommendations ([[claim-guideline-format-change-impact]]). The failure was surfaced by [[entity-gsk]]'s generative-listening audit and underpins open question [[question-ai-liability-governance]].

**Canonical context (enrichment):** Confirmed as the authoritative global COPD guideline body; hosts guidelines as PDFs/supporting documents that LLMs can struggle to parse when access/format changes.